Together, these findings imply some conservation in the role of AHR in repressing the TGFβ-SMAD pathway in brain tumour stem cells and suggest the possibility that inactivation or repression of this pathway may represent a mechanism whereby tumour cells retain a stem-like character and become resistant to differentiation. The gene discussed is AHR; the disease is brain neoplasm.